HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roper, N. A. Articles by Connolly, V. M. Search for Related Content PubMed PubMed Citation Articles by Roper, N. A. Articles by Connolly, V. M. Social Bookmarking                What's this?

Cause-Specific Mortality in a Population With Diabetes

South Tees Diabetes Mortality Study

¹ Diabetes Care Centre, Middlesbrough General Hospital, Middlesbrough, U.K.
² Department of Diabetes, University of Newcastle, Newcastle upon Tyne, U.K.
³ Department of Epidemiology and Public Health, University of Newcastle, Newcastle upon Tyne, U.K.

OBJECTIVE—To describe the mortality of a population with diabetes compared with the local nondiabetic population, using age-, sex-, and cause-specific death rates and relative and absolute differences in death rates.

RESEARCH DESIGN AND METHODS—A population-based cohort of 4,842 people with diabetes living within South Tees, U.K., was identified and followed from 1 January 1994 to 31 December 1999. Causes of death were obtained from death certificates, and mortality rates were compared with the nondiabetic population of the same area for the same time period.

RESULTS—There were 1,205 deaths (24.9%) in the study population during the 6 years of study. For type 2 diabetes, mortality from cardiovascular causes was significantly increased in both sexes and at all ages. Relative death rates for the age band 40–59 years were 5.47 (95% CI 4.18–7.15) for men and 5.60 (3.44–9.14) for women. The relative death rates declined with age for both sexes, but absolute excess mortality increased with age. There were no consistent differences in noncardiovascular death rates, other than for renal disease. Similar outcomes were found for type 1 diabetes, although these results were limited by a much smaller population size. People with diabetes and renal impairment had significantly higher mortality than people with diabetes alone, with a rate ratio of 7.27 for people with type 2 diabetes aged 40–59 years.

CONCLUSIONS—In an area of the U.K. with high cardiovascular death rates, people with diabetes had significantly higher cardiovascular death rates than people without diabetes. Interventions targeted at cardiovascular risk factors should be used to try and reduce this excess premature mortality, which is especially high in those with renal impairment.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				W. S. Cheng, D. L. Wingard, D. Kritz-Silverstein, and E. Barrett-Connor Sensitivity and Specificity of Death Certificates for Diabetes: As good as it gets? Diabetes Care, February 1, 2008; 31(2): 279 - 284. [Abstract] [Full Text] [PDF]

				L. N. McEwen, C. Kim, A. J. Karter, M. N. Haan, D. Ghosh, P. M. Lantz, C. M. Mangione, T. J. Thompson, and W. H. Herman Risk Factors for Mortality Among Patients With Diabetes: The Translating Research Into Action for Diabetes (TRIAD) Study Diabetes Care, July 1, 2007; 30(7): 1736 - 1741. [Abstract] [Full Text] [PDF]

				A. Nicolucci, S. Greenfield, and S. Mattke Selecting indicators for the quality of diabetes care at the health systems level in OECD countries Int. J. Qual. Health Care, September 1, 2006; 18(suppl_1): 26 - 30. [Abstract] [Full Text] [PDF]

				S. S. Soedamah-Muthu, J. H. Fuller, H. E. Mulnier, V. S. Raleigh, R. A. Lawrenson, and H. M. Colhoun High Risk of Cardiovascular Disease in Patients With Type 1 Diabetes in the U.K.: A cohort study using the General Practice Research Database Diabetes Care, April 1, 2006; 29(4): 798 - 804. [Abstract] [Full Text] [PDF]

				M. Collins and J. R. McFarlane An Exploratory Study Into the Effectiveness of a Combination of Traditional Chinese Herbs in the Management of Type 2 Diabetes Diabetes Care, April 1, 2006; 29(4): 945 - 946. [Full Text] [PDF]

				S. De Cosmo, R. Trevisan, A. Minenna, M. Vedovato, R. Viti, S. A. Santini, A. R. Dodesini, P. Fioretto, and V. Trischitta Insulin Resistance and the Cluster of Abnormalities Related to the Metabolic Syndrome Are Associated With Reduced Glomerular Filtration Rate in Patients With Type 2 Diabetes Diabetes Care, February 1, 2006; 29(2): 432 - 434. [Full Text] [PDF]

				L. F. Fried, R. Katz, M. J. Sarnak, M. G. Shlipak, P. H.M. Chaves, N. S. Jenny, C. Stehman-Breen, D. Gillen, A. J. Bleyer, C. Hirsch, et al. Kidney Function as a Predictor of Noncardiovascular Mortality J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3728 - 3735. [Abstract] [Full Text] [PDF]

				H. Gylling, J. A. Tuominen, V. A. Koivisto, and T. A. Miettinen Cholesterol Metabolism in Type 1 Diabetes Diabetes, September 1, 2004; 53(9): 2217 - 2222. [Abstract] [Full Text] [PDF]

				C.-H. Tseng Mortality and Causes of Death in a National Sample of Diabetic Patients in Taiwan Diabetes Care, July 1, 2004; 27(7): 1605 - 1609. [Abstract] [Full Text] [PDF]

				M Fisher Diabetes: can we stop the time bomb? Heart, May 1, 2003; 89(90002): ii28 - 30. [Abstract] [Full Text] [PDF]

				M. Fisher Prevention of macrovascular complications Eur. Heart J. Suppl., January 1, 2003; 5(suppl_B): B21 - B26. [Abstract] [PDF]

				Time2Take on Risk: Report of a GSK symposium from Diabetes UK, Birmingham, March 13th 2002 The British Journal of Diabetes & Vascular Disease, March 1, 2002; 2(2_suppl): s1 - S5. [PDF]